HUDEC, Martin, Petra VYSOČANOVÁ, Vojtěch BRÁZDIL, Martin POLOCZEK, Martin HETMER, Jiřina LITTLE, Martina DOUBKOVÁ and Petr KALA. Amiodaronem indukované postižení plic u pacienta s fibrilací síní (Amiodarone induced pulmonary toxicity). Vnitřní lékařství. Praha: Česká lékařská společnost J. E. Purkyně, 2021, vol. 67, No 7, p. "E18"-"E23", 6 pp. ISSN 0042-773X. Available from: https://dx.doi.org/10.36290/VNL.2021.116.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Amiodaronem indukované postižení plic u pacienta s fibrilací síní
Name (in English) Amiodarone induced pulmonary toxicity
Authors HUDEC, Martin (203 Czech Republic, guarantor, belonging to the institution), Petra VYSOČANOVÁ (203 Czech Republic, belonging to the institution), Vojtěch BRÁZDIL (203 Czech Republic, belonging to the institution), Martin POLOCZEK (203 Czech Republic, belonging to the institution), Martin HETMER (203 Czech Republic), Jiřina LITTLE (203 Czech Republic), Martina DOUBKOVÁ (203 Czech Republic, belonging to the institution) and Petr KALA (203 Czech Republic, belonging to the institution).
Edition Vnitřní lékařství, Praha, Česká lékařská společnost J. E. Purkyně, 2021, 0042-773X.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/21:00128163
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.36290/VNL.2021.116
Keywords (in Czech) AIPT; Amiodarone; Amiodarone induced pulmonary toxicity; Amiodarone lung
Keywords in English AIPT; Amiodarone; Amiodarone induced pulmonary toxicity; Amiodarone lung
Tags rivok
Tags Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2023 08:27.
Abstract
Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined. © 2021, SOLEN s.r.o.. All rights reserved.
Abstract (in English)
Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined. © 2021, SOLEN s.r.o.. All rights reserved.
PrintDisplayed: 23/9/2024 20:00